Premium
OC113: Prevalence and risk of trisomy 21 following negative (< 1/250) combined screening with maternal age, nuchal translucency and maternal serum markers at 11–14 weeks. A role for the genetic scan?
Author(s) -
Bernard J. P.,
Bussieres L.,
Rozenberg P.,
Ville Y.
Publication year - 2004
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1002/uog.1233
Subject(s) - trisomy , medicine , residual risk , obstetrics , down syndrome , advanced maternal age , population , gynecology , nuchal translucency measurement , risk factor , pregnancy , first trimester , fetus , genetics , biology , psychiatry , environmental health